V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014686 | 220009285 | 1.71 | 87.2 | Curative (C) | 2015-07-06 | 2015-07-27 | GemCarbo Days 1+8 | N | N | 220035094 | PONATINIB |
| 220014693 | 220009295 | 1.57 | 83 | Palliative (P) | 2017-07-03 | 2017-07-03 | Capecitabine + Oxaliplatin 21day | 02 | N | 220035112 | CAPECITABINE + OXALIPLATIN |
| 220014694 | 220009295 | 1.68 | 78 | Neo-adjuvant (N) | 2014-11-30 | 2014-12-02 | DOXORUBICIN | N | N | 220035112 | FCIST |
| 220014695 | 220009296 | null | 95.4 | Palliative (P) | 2014-07-16 | 2014-07-17 | MidAC | N | null | 220035126 | MELPHALAN |
| 220014697 | 220014940 | null | null | Palliative (P) | 2015-11-28 | 2015-11-30 | PAD | 99 | Y | 220035134 | MELPHALAN |
| 220014698 | 220014940 | null | 65.3 | Disease modification (D) | 2014-09-19 | 2014-09-19 | Methotrexate High Dose (3g/m2) | N | null | 220035134 | FEC |
| 220014699 | 220014940 | 1.91 | 29.9 | Palliative (P) | 2014-01-21 | 2014-06-26 | CTD (Thalidomide 100mg) | N | N | 220035134 | DAUNORUBICIN |
| 220014700 | 220009299 | null | null | Palliative (P) | 2016-02-19 | 2016-03-04 | IGEV R | N | N | 220035146 | LENALIDOMIDE |
| 220014701 | 220009303 | 1.83 | 99 | Curative (C) | null | 2016-10-14 | Cisplatin + Pemetrexed | N | N | 220035152 | TRIFLURIDINE + TIPIRACIL |
| 220014702 | 220009305 | 1.67 | 55 | Disease modification (D) | 2016-05-31 | 2016-06-30 | FIGARO TRIAL | 2 | N | 220035152 | CAPECITABINE + IRINOTECAN |
| 220014703 | 220009307 | 1.64 | 68.7 | null | 2017-05-06 | 2017-06-05 | Ipilimumab | 01 | N | 220035169 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220014704 | 220014942 | 1.76 | 60.8 | Curative (C) | 2013-04-06 | 2013-09-07 | MidAC | Y | N | 220035181 | EVEROLIMUS |
| 220014708 | 220009310 | 1.66 | 105 | Curative (C) | 2015-12-03 | 2016-01-14 | CETUXIMAB | 02 | N | 220035188 | CAPECITABINE |
| 220014709 | 220014944 | 1.71 | 78.6 | Curative (C) | 2016-06-25 | 2016-08-04 | CAPECITABINE + IRINOTECAN | N | N | 220035189 | PEMBROLIZUMAB |
| 220014710 | 220009316 | null | 70.5 | Curative (C) | 2016-05-04 | 2017-01-15 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 220035190 | ABIRATERONE |
| 220014711 | 220014945 | null | 73.25 | Curative (C) | 2016-08-02 | 2017-03-08 | BORTEZOMIB + THALIDOMIDE | Y | N | 220035195 | EOX |
| 220014713 | 220009320 | 1.56 | null | Palliative (P) | null | 2015-01-27 | FCR | 02 | null | 220035200 | UKALL2011 |
| 220014714 | 220009322 | 0 | 106.2 | Curative (C) | 2015-04-03 | 2015-04-10 | Carboplatin + Liposomal Doxorubicin | 2 | N | 220035212 | IFOSFAMIDE |
| 220014715 | 220018158 | null | 103 | Palliative (P) | 2014-03-11 | 2014-03-11 | Arsenic trioxide | N | N | 220035219 | ETOPOSIDE |
| 220014716 | 220009325 | 1.86 | 0 | Curative (C) | 2016-03-21 | 2016-04-27 | CAPECITABINE + IRINOTECAN | 02 | N | 220035224 | CISPLATIN + FLUOROURACIL |
| 220014717 | 220009325 | 1.49 | 56.2 | Curative (C) | null | 2018-02-01 | Vincristine (weekly) | 2 | Y | 220035224 | CYTARABINE IT + METHOTREXATE |
| 220014718 | 220009328 | null | 17.5 | null | 2015-08-25 | 2016-11-27 | GCLAC | N | N | 220035231 | LENALIDOMIDE |
| 220014719 | 220009329 | null | 9.4 | Radical (R) | 2016-12-14 | 2016-12-15 | BUSULFAN + CYCLO | N | null | 220035232 | LENALIDOMIDE |
| 220014720 | 220009330 | null | null | Curative (C) | 2014-12-20 | 2014-12-26 | DHAP | N | null | 220035241 | EPIRUBICIN |
| 220014721 | 220009330 | null | 65 | Disease modification (D) | 2013-04-20 | 2013-04-30 | DOCETAXEL + GEMCITABINE | N | N | 220035241 | LI-1 TRIAL |
| 220014722 | 220019966 | null | null | null | 2015-09-13 | 2015-09-20 | CHOP R - 21 days | null | null | 220035243 | CHLVPP |
| 220014723 | 220014952 | 1.77 | 13 | Disease modification (D) | 2016-08-26 | 2017-06-21 | CARBOPLATIN + RT | 2 | N | 220035265 | DABRAFENIB + TRAMETINIB |
| 220014724 | 220009333 | 1.66 | 78.4 | Palliative (P) | 2013-09-19 | 2013-09-19 | Capecitabine (21 day) + Irinotecan | N | N | 220035268 | CLADRIBINE + CYTARABINE + DAUNORUBICIN |
| 220014725 | 220009334 | null | null | null | 2016-03-14 | 2016-03-19 | MELPHALAN | null | N | 220035271 | UKALL2011 |
| 220014726 | 220014953 | 1.73 | 87.1 | Curative (C) | 2016-02-05 | 2016-02-05 | PEMBROLIZUMAB | N | N | 220035271 | BUSULPHAN |
| 220014727 | 220009335 | null | null | null | 2013-12-13 | 2014-01-05 | CVAD | Y | N | 220035279 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220014728 | 220014954 | 1.64 | 76 | Palliative (P) | 2016-08-16 | 2016-08-27 | PEMBROLIZUMAB | 01 | N | 220035292 | TEMOZOLOMIDE + RT |
| 220014729 | 220009338 | 1.72 | 59 | Disease modification (D) | 2013-12-17 | 2013-12-29 | PEMBROLIZUMAB | N | N | 220035295 | TRASTUZUMAB |
| 220014730 | 220014955 | 1.83 | 101.6 | Palliative (P) | 2014-02-10 | 2014-02-13 | Sunitinib | N | N | 220035295 | LIPOSOMAL CYTARABINE |
| 220014731 | 220014956 | 1.75 | 55 | Disease modification (D) | 2015-07-23 | 2015-07-23 | Cisplatin + Pemetrexed | 02 | N | 220035304 | IPILIMUMAB + NIVOLUMAB |
| 220014732 | 220014956 | 1.67 | 78.4 | Palliative (P) | 2014-11-05 | 2014-11-13 | DABRAFENIB | 01 | N | 220035304 | CYTARABINE + MITOXANTRONE |
| 220014733 | 220014956 | null | null | Adjuvant (A) | 2018-06-13 | 2018-06-13 | R GCVP | 99 | N | 220035304 | GEMCITABINE |
| 220014734 | 220021920 | 1.57 | 63 | Palliative (P) | 2018-03-13 | 2018-03-13 | Melphalan IV High dose | N | N | 220035316 | CHOP R |
| 220014735 | 220022274 | 1.53 | 64.1 | Palliative (P) | 2013-03-18 | 2013-03-19 | MELPHALAN | null | N | 220035320 | UKALL 2011 |
| 220014736 | 220009342 | 1.7 | 69.6 | Palliative (P) | null | 2015-08-12 | CISPLATIN + FLUOROURACIL | N | N | 220035326 | POMALIDOMIDE |
| 220014737 | 220009343 | 1.77 | 127 | Palliative (P) | 2017-10-19 | 2017-10-19 | MERCAPTOPURINE + METHOTREXATE | 02 | N | 220035327 | CHOP R |
| 220014738 | 220009344 | null | null | Curative (C) | 2014-12-12 | 2015-01-21 | DAUNORUBICIN | N | null | 220035327 | TRASTUZUMAB |
| 220014739 | 220009347 | 1.63 | null | null | 2013-08-21 | 2013-08-21 | Carboplatin + Liposomal Doxorubicin | N | N | 220035332 | MIDAC |
| 220014740 | 220009348 | 1.8 | 83.2 | Curative (C) | 2017-12-29 | 2017-12-29 | CISPLATIN + FLUOROURACIL | N | N | 220035332 | VIDE |
| 220014741 | 220009349 | 1.8 | 102.2 | Disease modification (D) | 2015-02-14 | 2015-02-14 | Carboplatin AUC 6 - 10 | N | N | 220035338 | BEVACIZUMAB |
| 220014742 | 220009350 | 1.79 | 118.5 | Palliative (P) | 2014-11-21 | 2014-11-21 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 220035340 | TRASTUZUMAB |
| 220014743 | 220014963 | 1.56 | 78.4 | Not known (9) | 2013-03-14 | 2013-04-03 | OSIMERTINIB | 02 | N | 220035347 | IPILIMUMAB |
| 220014744 | 220009353 | 1.72 | 96.7 | Palliative (P) | 2015-12-05 | 2015-12-05 | Capecitabine | 02 | N | 220035350 | ALL MAINTENANCE |
| 220014747 | 220009357 | 1.75 | 72.5 | Curative (C) | 2015-02-06 | 2015-02-13 | CAPECITABINE + GEMCITABINE | 2 | N | 220035373 | BEVACIZUMAB |
| 220014748 | 220009361 | 1.8 | 74 | Disease modification (D) | 2018-06-26 | 2018-07-14 | Bendamustine + prednisolone | N | N | 220035373 | EPIRUBICIN |